European shares rise on possible easing of COVID-19 curbs, vaccine progress
Reuters
Published Nov 24, 2020 03:25AM ET
(Reuters) - European shares gained on Tuesday as a possible easing of lockdowns in France added to a brighter mood from encouraging developments related to coronavirus vaccines.
The pan-European STOXX 600 index was up 0.8% at 0805 GMT, supported by gains in travel stocks and the oil and gas sector after global crude prices hit their highest levels since March.
France reported its lowest daily tally of COVID-19 infections since Sept. 28 on Monday, with investors now focused on a speech by President Emmanuel Macron later in the day when he may announce a relaxation of lockdown rules.
The country's benchmark CAC 40 was up 0.9% in early trade.
Germany's DAX rose 0.9%, with exchange operator Deutsche Boerse (DE:DB1Gn) revealing that the blue-chip index will expand to 40 from the current 30 companies with tougher membership criteria.
Data showed Germany, Europe's largest economy, grew by a record 8.5% in the third quarter, but the outlook remains clouded by a second wave of virus infections and a partial lockdown to slow the spread of the disease.
In company news, Phoenix Group Holdings fell 0.1% as the London-based insurer said it was assessing a range of strategic options for its European businesses.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.